Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB3 | P13945 | 9/20 | 0.44 |
| ▸ | ADRB1 | P08588 | 8/20 | 0.41 |
| ▸ | MMEL1 | Q495T6 | 1/20 | 0.41 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.40 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6677081 | 0.93 | CYP4F2 (0.42) | ADRB3ADRB1CYP4F2CYP4A11ALDH1A1 | |
| SCHEMBL6680801 | 0.90 | ADRB3 (0.46) | ADRB3ADRB1CYP4F2CYP4A11ALDH1A1 | |
| SCHEMBL6681933 | 0.89 | ADRB3 (0.42) | ADRB3ADRB1CYP4F2CYP4A11ALDH1A1 | |
| SCHEMBL6679530 | 0.86 | ADORA1 (0.38) | ADRB3ADRB1ALDH1A1ADRB2 | |
| SCHEMBL6687818 | 0.86 | ADRB3 (0.39) | ADRB3ADRB1ALDH1A1ADRB2 | |
| Hydrochloric Acid SCHEMBL6682209 | 0.82 | ADRB3 (0.59) | ADRB3ADRB1ADRB2 | |
| SCHEMBL6679246 | 0.81 | ADORA1 (0.40) | ADRB3ADRB1ALDH1A1ADRB2 | |
| SCHEMBL6676594 | 0.81 | ADRB3 (0.42) | ADRB3ADRB1ADRB2 | |
| SCHEMBL6677034 | 0.80 | ADRB3 (0.44) | ADRB3ADRB1CYP4F2CYP4A11ALDH1A1 | |
| SCHEMBL6677426 | 0.80 | ADRB3 (0.61) | ADRB3ADRB1ADRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004045610-A1 | AMINOALCOHOL DERIVATIVES AND THEIR USE AS BETA-3 ADRENERGIC RECEPTOR AGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD (JP) | 2004-06-03 | — | — | WO | disclosed |